Study for type 2 inflammatory skin rashes and hives
Part of Immune system & allergy, Skin clinical trials.
This study looks at people with certain types of inflammatory skin conditions to improve how they are diagnosed and treated. It may help your care team by using a standardized approach, but you must be able to complete questionnaires and consent to participate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have one of these conditions: dermatitis/eczema, hives (urticaria), pemphigoid, or nodular prurigo
- You are being seen through a participating hospital clinic for skin and immune diseases (study sites)
- You can review and sign an informed consent form
- You can complete the study questionnaires on your own or with help from the study team
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at what affects the “path” (trajectory) of long-lasting inflammatory skin conditions. It may help researchers understand why symptoms change and how treatments or factors influence those changes.
This study tests a new medication called IBI3002 for people with moderate to severe eczema (atopic dermatitis) that hasn't been well controlled by standard creams. The goal is to see if IBI3002 can reduce skin inflammation and itching.
This study looks at different skin diseases to find markers that can help guide treatment. It tests new treatments for several conditions like eczema, psoriasis, and lupus, with the goal of personalizing care.
This study looks for clues in your skin and blood that could predict how well you'll respond to treatments for conditions like eczema, psoriasis, or lupus. It aims to help doctors choose the best therapy for you.
This trial looks at how well standard treatments work for chronic skin conditions like atopic dermatitis, prurigo nodularis, psoriasis, chronic hand eczema, and hidradenitis suppurativa. It's observational, so it just tracks your progress during your normal care.
This study looks at molecular (body-level) signatures in people with chronic inflammatory skin conditions. You may help researchers understand what drives inflammation, while receiving standard (already approved) systemic treatment through routine care.
Hear when a new Atopic Dermatitis (Eczema) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.